DMBA (7,12-dimethylbenz-[α]-anthracene) is a commercial chemical agent used to induce breast cancer in preclinical models by activating cellular cytosolic receptor aryl hydrocarbon receptor (AhR). Here, AHR is linked to breast carcinoma.